NCT06123286View on ClinicalTrials.gov

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Breast CancerAromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)Joint Pain
Interventions
DRUG

Tart Cherry

1 ounce of Tart Cherry Concentrate (King Orchard) mixed with 8 ounces of water daily for 12 weeks

DRUG

Omega 3 FA (Fish Oil)

2 capsules of Omega 3 FA (Fish Oil) (Nordic Naturals Ultimate Omega) \[650 mg EPA and 450 mg DHA per capsule\] daily for 12 weeks

Trial Locations (2)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

90505

NOT_YET_RECRUITING

CS Cancer at the Hunt Cancer Center, Torrance

All Listed Sponsors
collaborator

The Cherry Marketing Institute

UNKNOWN

lead

Philip Chang

OTHER